Prosecution Insights
Last updated: October 02, 2026

Examiner: WISTNER, SARAH CLINKSCALES

Tech Center 1600 • Art Units: 1616

This examiner grants 25% of resolved cases

Analysis

Sarah Clinkscales Wistner is an examiner in Tech Center 1600 and Art Unit 1616. She has 28 resolved cases with an allowance rate of 25.0 percent. This 25.0 percent rate indicates the proportion of applications that reach issuance under her review. The median days to allowance of 1297 provides a timeline for the duration of the prosecution process for successful cases. Practitioners should use this timing metric to plan their patent strategy and manage expectations in Tech Center 1600.

The interview lift of 81.0 percent suggests that conducting an interview significantly increases the probability of a grant. This 81.0 percent lift is a key metric for practitioners deciding whether to engage in direct communication with the examiner to resolve rejections. With 28 resolved cases, the data reflects an initial examination history. The median days to allowance of 1297 is a useful figure for managing the expected timeline of a patent application. Utilizing the interview process appears to be a critical component for navigating Art Unit 1616.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

25.0%
Allow Rate
-35.0% vs TC avg
80
Total Applications
+81.0%
Interview Lift
1297
Avg Prosecution Days
Based on 28 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
15.1%
§102 Novelty
35.0%
§103 Obviousness
24.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19083627 HEMOSTATIC COMPOSITIONS AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18618015 LIQUID EMBOLIC MATERIALS Final Rejection Boston Scientific Scimed, Inc.
19050493 RESIN PARTICLES AND COSMETIC PREPARATION Non-Final OA FUJIFILM BUSINESS INNOVATION CORP.
19062173 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS Non-Final OA The Procter & Gamble Company
18265721 C13 - HYDROCARBON MIXTURE AND USE THEREOF Final Rejection BASF SE
17780015 METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS MATERIAL, ESPECIALLY HUMAN HAIR Final Rejection Henkel AG & Co. KGaA
19002887 NOVEL PHOTONIC CRYSTAL PROTEINS FROM ATRINA SP. BYSSUS AND USES THEREOF Non-Final OA POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
18618199 LONG-WEAR COMPOSITIONS Final Rejection L'OREAL
18253667 COMPOSITION COMPRISING A PARTICULAR OXIDATION DYEING BASE, AT LEAST ONE GUAR GUM AND AT LEAST ONE FATTY SUBSTANCE Non-Final OA L'Oreal
18041744 STABLE COMPOSITION COMPRISING POLYDATIN Final Rejection L'OREAL
18071946 HAIR REMOVAL POLYMERIZATION SYSTEM AND METHOD Non-Final OA L'OREAL
17796888 COATING AGENT AND MEDICAL MATERIAL USING SAME Non-Final OA Toray Industries, Inc.
18973959 Oral Care Compositions Non-Final OA Colgate-Palmolive Company
18770842 COMPOSITION FOR SOLID DISPERSION, SOLID DISPERSION, AND METHOD OF MANUFACTURING THE SOLID DISPERSION Non-Final OA Shin-Etsu Chemical Co., Ltd.
17788271 FIBER TREATMENT AGENT COMPOSITION Final Rejection KAO CORPORATION
17979134 SYNTHETIC SURGICAL HEMOSTAT Final Rejection BAXTER HEALTHCARE SA
18276518 MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION Final Rejection SYMRISE AG
18795174 SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS Non-Final OA AdvanSix Resins & Chemicals LLC
17948277 Refillable Implantable Device for Delivering a Drug Compound Non-Final OA Celanese EVA Performance Polymers LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month